look at google. look at that stock up another buck, almost two. ten year gain up more than 1,000%. near its all time highs today. is this stock worth $1100? maybe even more, do i hear $1200? a lot of big movers today. sue will tell you about some of them at the new york stock exchange. i sure am, thank you. let's get a check of the markets, first. the dow is down a little today, about 78 points on the trading session. the s&p is flat, the nasdaq is up but the big picture doesn't really tell the story today. so we have several really big movers. remember when we used to talk taser? all the time, practically? the stock is up big today on new orders. riverbed technology also up big as elliott management offers to acquire that company. soda stream got an upgrade. the stock is bubbling higher and sandisc is up. plus, there's forest labs, which is buying apdale's and micron and constellation are up on earnings. sales of mckesson corporation up as well. fleer announcing a new product for smartphones using heat sensing technology. also on the radar, the oil market, which has really been all over the map, has fallen about 3% in the last week or so. today, just a fractional move to the upside with crude at $107.40. bob pisani is on the floor with us. yesterday we felt like the market had a little bit of kind of legs underneath it. >> a little disappointing. adp numbers were good, yet the market never really responded. i would note financial stocks continuing to rally. health care is also a big winner. they are the two winners so far this year. take a look at what's moving here. i think the important thing here right now is earnings. micron, great numbers. sue mentioned constellation. great beer sales from them. they raised their 2014 eps guidance. that's the winner here. we're waiting for more positive commentary. this is the first one. monsanto also better than expected. the real problem we're having is china is off to a rocky start. it's really hurting the commodity name so steel stocks, for example, there's the xme which is energy stocks, the xop, that's oil stocks, and steel stocks, slx, they have all had a rough start to the year overall. finally, a lot of downgrades as people adjust for valuation. some food names were downgraded by deutsch bank. we got an upgrade of hershey's and kraft food got an upgrade. it's had its own problem because there apparently is a shortage of velveeta out there. my hometown of philadelphia is in a tizzy because it's a critical ingredient in cheesesteaks. why there's a shortage of processed food is beyond me. it's got people very, very worried. this is done via twitter by advertising agents. thank you for that breaking news there. >> thank you, bob. see you later. yesterday we had a weak three-year note auction. let's see how the ten-year, the benchmark went off the boards. rick santelli is back, thank goodness, to give us his grade on the auction. >> well, this is a "c" for charlie. charlie is what we give on the grade. very average. let's go through. it was $21 billion reopen, original auction held two months ago. the ultimate yield on this reopening, 3.009. a lot of decimal places. last time we had a three on this was in may of 2011, to give you some context. here's why it's average. average bid to cover last ten options, 2.70. this one snuck right in there at 2.68. 46.6 on indirect, 43% ten auction average. we're a little heavy there. we were a little light on directs at 13.6 and dealers took 39.8, a little less than 40%. maybe that's good news. but in the end, this was average from top to bottom. tyler and sue, back to you. >> rick santelli, thank you very much. three big stock stories also on the radar. sheila dharmarajan watching it. josh lipton on google's good year so far. but we start with dominic chu and some stocks that are getting a real boost from the big tech show out in las vegas. take it away. >> the big companies are always going to get the headlines but here are some of the fun ones. sue alluded to one earlier. that's fleer systems. this company, fleer, you got to think about night vision but thermal imaging, these guys do a lot of that kind of work. what they have announced is a new app for your iphone that can do thermal imaging as well. if you talk about the way the stock has performed, check this out, because this company, it really has done well in this new thermal technology, it could be good for the iphone and good for sales going forward as well. also one you want to watch, also touch screenish for phone and ipads, a new product could revolutionize notebook computers going forward. it's magnetic which lets you have not just a keyboard but also a touch screen function for that as well. that company is doing pretty well in terms of its stock as well. now, the last one i want to talk about here is i-robot, a stock that's been on a tear, you can see up about 9% over the past call it day or two here. this company has just unveiled a new robot vacuum and mopping mechanism that also disinfects. it's pricey, it will cost about $600. still, i-robot does a lot of these type of products and tyler overall, this stock has been on a tear. one of the best performing stocks in this group over the last year. >> look at that thing go, man. that is beautiful. my son will want one of those. thank you very much. let's go out to josh lipton and talk a little more about google's big run. josh, my argument is that whenever your company name becomes a verb or generic term, you have made it. >> reporter: i think investors agree with you. google has been on a tear. analysts think it could move higher from here, the stock hitting another record today after skyrocketing up nearly 60% in 2013. that was its biggest annual gain since 2009. 69% of analysts have a buy rating on the stock right now. the bold pace, listen, it's a play on online advertising, dominant market share in search, youtube which analysts estimate already generates $5 billion a year in revenue, will benefit from the move to online ad dollars and google, it's an early leader in wearables as well. yes, glass is geeky but it could be cool in a few years with the right design. technicians also on the google bull band wagon. mark newton is gray wolf's chief technical analyst, telling cnbc that google is a buy. resistance is at 1175 with support at 1105. but not everybody is a google believer. jordan rowhan is one of the few on the streets that rates google a hold. his big concern, no surprise, the stock is too expensive, he says. google is trading at around 22 times forward earnings. that's about 30% above its five year average. so who is right? we will get the latest on google's financials when it reports fourth quarter earnings on january 30th. back to you. >> thank you very much. sheila dharmarajan with another great stock story for today. 2013 laggards who have been putting up good numbers so far this year. sheila? >> reporter: let's start off with teradata, down a whopping 27%. take a look at the last month, the stock is up over 10%. what is going on? analysts tell me look, this is a company that has really expensive products. in fact, the average bill is about $1 million. last year, companies weren't really willing to pay that. they were worried about their budgets and the economy so the company couldn't sign deals and basically whiffed on its earnings numbers. now perhaps the economy is on solid footing, companies feeling a little bit more confident, so we are starting to see a turnaround in these shares but analysts do warn me this is a show-me story. the company still has to put up those numbers. the number two i got a retailer for you, called five below. this is a fun store. i don't know if you have ever been in one. they sell all sorts of little cheap trinkets aimed at the tween market. had a decent 2013 but you can see the stock completely fell off around october, november, when the company reporting earnings. basically had light guidance going forward. now you are starting to see a little bit of life in five below. what is going on? i spoke to analysts who said look, this is a company that is known for always guiding pretty low. they are known for this guidance game. he thinks the holiday traffic has been really strong. rainbow looms, that crazy toy, has been part of it. he says big picture, when you take a look at this stock, the company has 300 stores now, could be going to 2,000 stores. last stock i got for you is one we love to talk about, blackberry. terrible year last year. blackberry turning around now, all about can this company be turned around. we have to wait and see. >> thanks very much. let's move now to seema mody for a market flash. >> good afternoon. check out shares of jc penney hovering near session lows while the struggling retailer said it was pleased with its holiday sales performance though it rattled investors by not providing any details on those sales. the stock trading down around 8%. sue? thank you very much. a developing story just a few blocks from where we are right now. the jury selection is under way in the case of another former sac capital trader. kate kelly is on that story for us. what do you have? >> reporter: i'm standing in front of the court where the jury pool is currently being questioned by the judge. there are about 40, 45 people still in the room at last check and they are going through a number of questions about legal background, any connections or biases against the united states or against sac. a few people have been eliminated but interestingly, the jury pool which i would say is predominantly white and middle aged, contains a woman whose cousin actually was an employee of sac capital at some point. she has not been eliminated, nor has a gentleman who actually runs a debt capital markets unit at a bank. so some interesting perspectives we may find in that jury pool. of course, they have to get it down to 12 plus the alternates. hopefully that will happen sometime today, maybe within the next hour or two, after which we get opening arguments. just a reminder, this case involves insider trading by a fom former sac capital trader. he stands accused of conspiracy to commit securities fraud, and generating gains that averted losses of a quarter billion dollars. one final note, an important judge's ruling from earlier today is that a deposition taken by sac founder and owner steve cohen, who is kind of a key player in some of the sequencing of events in this case, will not be able to be introduced into evidence. that's something i think that the defense was hoping they would be able to introduce but they have not been permitted to. we won't be hearing that. >> that is very interesting. kate, thank you very much. we will get back to you as that jury pool is winowed down. meantime, the adp number today showing a big jump in construction jobs, up 48,000 in december. the question is, will that translate into a better than expected year for home builders? will randow joins me on the floor of the nyse. thanks for joining us. it was an exceptionally strong number in construction jobs, but does that necessarily translate into a better year for housing? >> i think it does. ultimately one of the key constraints with home builders has been a lack of labor supply, among others. we saw over the last year two million jobs were added according to the adp data, only 10% of which were construction. now we are seeing this big jump, 48,000 jobs added in december, relative to only about 238 for adp numbers as a whole. this is a great thing. >> you have been bullish on the home builders. you were early on that call. so far you have been right. in that sector, which stocks are you perhaps the most bullish on? >> i'm the most bullish on we like i guess special value or special situation names. brookfield residential properties is one of our favorite names in this space. we think that could be a double over the next two years and probably into the high 20s this year as they unlock their portfolio of grossly undervalued land. another name is d.r. horton. that's more of a large builder among the larger caps. what's interesting about that name, people think first home home buyers have gone away. a lot of it has been distressed has pushed them out and other reasons, but end of the day, i think the name is hated and will become less hated and more loved. >> you like william lyon homes as well. before we let you go, interest rates bumping up against 3% which obviously is not skyrocketing. however, that translates generally speaking into higher mortgage rates. how much of a head wind will that be for housing? >> each 50 basis point increase could equate to 10% less affordable home. right now, we're at 25% more affordable than we have been since the 1980s. it really comes down to job growth. right now anything about household incomes, they are only 1% higher than the median since 1980. if we get real job growth, housing stocks are going higher. >> thank you so much for joining us. we appreciate it. we will talk about housing again because diana olick is here with a very unique slice of life from the front lines. diana? >> reporter: yesterday, we took you to an atlanta area foreclosure auction where the bidders could only see the outside of the houses that they were buying. today, they got to go in and we went along with them. we'll show you what we saw coming up next. >> look forward to that. plus, a new super bug that is scaring doctors, nurses, patients, pretty much everybody. we'll talk about what's being done to try and stop that new strain. more "power lunch" in two minutes. [ male announcer ] the new new york is open. open to innovation. open to ambition. open to bold ideas. that's why new york has a new plan -- dozens of tax free zones all across the state. move here, expand here, or start a new business here and pay no taxes for ten years... we're new york. if there's something that creates more jobs, and grows more businesses... we're open to it. start a tax-free business at startup-ny.com. yesterday we took you inside the first major foreclosure auction of 2014. we know big institutional investors were buying but what kind of properties did they buy? diana olick knows. she's in the suburbs of atlanta and will give us a first-hand look. >> reporter: that's right, more than 1,000 atlanta area homes sold at foreclosure auction yesterday. this is one of them. it was bought by key property services. now, they will rehab this home, they will get a renter inside it, and then they will sell it to another investor as a turnkey package. but they have a lot of work to do first. namely, they had to break in because there's not exactly a realtor waiting on the front lawn with a welcome key. so we went along with project manager kyle sweet this morning. >> my master key. >> reporter: there you go. all right. let's go inside. tell us what you do when you come into these homes. >> what we're looking at, to see if there's any plumbing or electrical that has been stolen, any damage to walls. they took the stove, they took the microwave. that is not uncommon for our condition. the floors look to be in good shape. there's no damage to any walls, ceilings are intact. >> reporter: what do you sometimes encounter in these houses? that was pretty easy to break into. >> our assessments can be as much as plumbing is stolen so you will see damage to the sheetrock, plumbing taken out, you will see electrical taken out on our extreme conditions, sometimes ceilings have been falling in. >> reporter: what have you had to do to get into houses? i have been told you can actually go through the doggy door? >> we use doggy door access when we need to. you have window access and you have the doors themselves, sometimes in the worst conditions of homes, you will have literally windows that don't exist or doors that have been busted open. >> reporter: let me ask you about the dangers. what could you possibly encounter and how do you protect yourself? >> the worst danger you will have is through a squatter, somebody residing inside the property that shouldn't be there in the first place. typically a lot of our drivers or assessors will go and actually carry weapons on them. >> reporter: sweet had some amazing stories to tell. he has crawled through doggy doors, he has crawled through basement windows, barely three feet wide. he has found squatters on the premises. he's broken into over 3,000 homes in his career and he set off to look at the more than 130 properties that just key bought alone yesterday. so he has plenty of work ahead of him. as for the trade here, they bought this home for $80,000 at auction. sweet says it will take about $20,000 to get it back up into good shape so they can rent it, then they will sell it to an investor for about $130,000, net profit on the one home, $30,000. but again, they bought 130 properties just yesterday. that's one small investor. blackstone was at the auction as well. they likely bought many more than that. sue? >> two quick questions. one, do they have to pony up with all the cash completely for these properties before they get them, and do they do most of the work themselves to increase the profit when they then flip the home? >> reporter: this has actually become a well-oiled machine. we talked about it years ago that they were trying to find people to rehab and maintain them and manage them once they rented out but they are putting all cash into these, number one. number two, they have entire teams. when i say they have 130 homes to see today, it's not just kyle sweet. they have a team of dozens of people on the ground here in atlanta. they will go to every one of those homes today. there was a locksmith here today. there was an assessor here today to look at all the parts of the home that need to be redone. they will remodel the homes themselves. they have that in-house. not all investors have that but most of the big ones do. that's how they keep the costs down. they get them done quickly, they turn them around to rent and sit and wait for the profit. >> great story. thanks so much. appreciate it. let's go uptown to seema mody for a market flash. >> check out shares of astra zeneca moving higher. the medicine was co-developed with bristol-myers squibb but astra-zeneca bought them out last year. shares up fractionally on the day. chicago area hospitals, the latest to be hit by a so-called super bug, a deadly drug defying bacteria that kills tens of thousands of americans every year. here to tell us more about this super bug outbreak and the handful of drug makers racing to find a cure, dr. william shafner, professor of infectious diseases at vanderbilt. welcome to "power lunch." let me begin, doctor, what is the name of this bacteria, where does it come from and who and where does it hit hardest? >> it has a big long name. only we can pronounce it. it's a very resistant bacteria that's been bred, evolved because we use so much antibiotics and now it's come out and can affect patients, mostly patients in hospitals. >> mostly patients in hospitals, nursing homes as i understand it, v.a. facilities. how prevalent is it and who does it hit hardest? >> well, at the moment, it's not all that common but it's been increasing slowly but steadily, and we are looking around the country to see where it is and to curtail its spread. it affects mostly people who are very ill who have received a lot of antibiotics often in intensive care units, and you also mentioned nursing homes. >> how deadly is it, doctor, and can you either be exposed to the bacteria or actually carry it and not get sick? >> exactly. it can be deadly because it affects often people who are already very ill. and yes, you can carry it in your intestinal tract and be completely without symptoms, but you're capable of spreading it to others. >> let me bring in barbara ryan, who follows the pharmaceutical sector for us. are there any drugs you know of that are effective against this illness and are there any in the pipeline? >> well, i think the answer is no, and that's really what is scary. one of the challenges that we face is that the incentive for pharmaceutical companies really hasn't been there in the antibiotic field, and that's forced a lot of companies to leave that arena. there are companies that are focused on that. roche just did a big deal with a private company in switzerland focused on developing treatments for these so-called super bugs. merck, pfizer, still in the antibiotics research field. antibiotics are acute use drugs. they are used for a very short period of time. there is a very high hurdle to getting these drugs approved because we have a lot of safe and effective drugs and they are generic and therefore very, very cheap and the newer agents, because of the challenges that the doctor walked through in terms of resistance are often held in reserve because we want these drugs to be ultimately effective when we really need them, not to be used as first line therapy, and then quickly develop the resistance that we already see occurring. >> so drugs to fight this, i'm hearing you say, are some years away. >> that's true. yes. >> doctor, let me come back to you. so treatment does not sound like the better way to fight this strain of unpronounceable bacteria. you did a beautiful job pronouncing it. i was hoping i didn't have to and you saved me. how do you prevent it? is it hand washing? what is it? >> yes, prevention is key, of course. we are trying to prevent all hospital associated infections, everything from good disinfection processes to actual rigorous hand hygiene by everyone who works in the hospital. as regards treatment, we're having to reach back into the older medicine cabinets and reactivate antibiotics that we haven't used for a long time, some of which may be a little bit more toxic. so it's an uncomfortable situation. prevention is the key. >> doctor, thank you very much for walking us through it. barbara ryan, great to hear from you. sue? >> thank you both so much. >> terrific conversation. small cap stocks were on fire in 2013, well outperforming their big cap rivals. will that incredible run continue in 2014? how to play it. plus -- >> coming up, power pitch. startups give us their 60-second pitch. we give you insight into the fast-paced world of venture capital. >> is your product something that really helps people quit smoking? >> do these founders have what it takes? >> we need to work out whether you are in or whether you are out. >> stay tuned. i'm beth... and i'm michelle. and we own the paper cottage. it's a stationery and gifts store. anything we purchase for the paper cottage goes on our ink card. so you can manage your business expenses and access them online instantly with the game changing app from ink. we didn't get into business to spend time managing receipts, that's why we have ink. we like being in business because we like being creative, we like interacting with people. so you have time to focus on the things you love. ink from chase. so you can. and it feels like your lifeate revolves around your symptoms, ask your gastroenterologist about humira adalimumab. humira has been proven to work for adults who have tried other medications but still experience the symptoms of moderate to severe crohn's disease. in clinical studies, the majority of patients on humira saw significant symptom relief, and many achieved remission. humira can lower your ability to fight infections, including tuberculosis. serious, sometimes fatal events, such as infections, lymphoma, or other types of cancer, have happened. blood, liver and nervous system problems, serious allergic reactions, and new or worsening heart failure have occurred. before starting humira, your doctor should test you for tb. ask your doctor if you live in or have been to a region where certain fungal infections are common. tell your doctor if you have had tb, hepatitis b, are prone to infections, or have symptoms such as fever, fatigue, cough, or sores. you should not start humira if you have any kind of infection. ask your gastroenterologist about humira today. remission is possible. welcome back. i'm sharon epperson. as the final trades are coming in here in the gold pit, we're looking at gold prices closing right now down about $5, right around $1224 an ounce. we have seen gold extend its losses after that positive report we got on private sector jobs from adp earlier this morning. in fact, we're looking at the third straight session that gold prices have fallen, and we are also watching what is happening in terms of physical demand for gold. of course, a lot will depend on what happens with the fed minutes this afternoon, traders are saying, but we have seen physical demand pop up since the fed announced on december 18th that it will taper its bond buying program. it could influence the gold trade this afternoon. back to you guys. >> thank you very much. time for our series the "power pitch." founders get 60 seconds to make their pitch and our panel of experts decides if they've got what it takes to become the next big thing. >> i'm maggie curry. on today's power pitch we have a company that wants to help you quit smoking. with this, herbal tea, and no nicotine is included. matt buckland is the president of quit tea. let's take a look at his power pitch. >> i'm matt buckland, creator of quick tea. i used to be a pharmaceutical analyst but i was always into natural health and quit smoking using herbs. i completely lost my taste for cigarettes and that inspired me to do research into herbs for quitting smoking. my unique idea for quit tea was to put the herbs into tea form, help replace the hand-to-mouth habit of smoking because it's easier to replace a habit than it is to break one. quit tea is a blend of herbs and spices that's relaxing, good for the lungs, good for detoxing and help produce hunger. i wanted to address all the major issues with giving up smoking in one tea. we started selling in 2011 and since then, almost a quarter million people have tried it. quit tea is at the intersection of the natural products industry and the number of people trying to quit smoking. just in the u.s., there are over 40 million smokers and it's a $1 billion a year industry without a lot of options. it is our goal to help replace the habit of smoking with drinking herbal tea. the key to long term success. >> matt is on the right side of the screen. he can hear us but can't react just yet. our power pitch panel today, entrepreneur joe vestianage, who runs dozens of restaurants. he was also a chain smoker for nearly 20 years of two to three packs a day. he successfully quit. we also have entrepreneur and investor chris schroeder who co-founded and was the ceo of health central.com, one of the largest platforms in health and wellness in the united states. he sold the company back in 2011. let's huddle up on quit tea. chris, what are your feelings? >> i'm curious about the marketing expenses and how he gets this in front of people with a lot of the noise out there with both herbal remedies and many pharmaceuticals that are advertising to the space. >> joe? >> quitting smoking is one of the most difficult things i ever did. i know a lot of people would invest money into products that will help them quit. it will be interesting to see how effective this product is. >> i think it's great to have a healthy alternative out there to whether chemically sort of processed nicotine replacement products. at the same time, he's been moving so fast, i would like to know where he will get the money for the next leg of growth. let's bring him in. matt, come sit down. let's ask you a few questions. great to meet you. >> great to meet you, too. >> joe -- >> what kind of dollars do you think it would take to make this message really resonate in the public and get the word of your product out there? >> the most effective marketing for us has been the free sample program. when i put it up when i first started selling because i wanted everybody to try a cup of quit tea before making the decision to buy and go ahead with it, i was doing about 50 a week by hand. it quickly went viral and i have been sending 10,000 samples a month. >> chris? >> do you envision that eventually you must be retail to grow and succeed and you will have to cut a deal there? >> it's in whole foods in the grocery department. some of the regions right now. it's on walgreens.com. it's really starting to expand in the retail market. >> can you talk about any either behavioral or scientific research that supports tea and your product as something that really helps people to quit smoking? >> there is actually a lot on the substitution strategy of quitting smoking. it's all about reconditioning the habit to replace it with something else and there is going to be triggers for you to want to smoke the rest of your life. but eventually, you can change those triggers to do something else like go make a cup of herbal tea. >> it says on the side of the box, repeat for at least nine weeks. so after nine weeks, is that the point at which you feel you might be, for want of a better word, cured of wanting to smoke? >> i put nine weeks on there because there is a lot of research that suggests that you can create a new habit within nine weeks. >> it's profitable? >> it's profitable. >> how much capital do you think you will need if you really want to grow? >> i don't think i will need too much. a quarter million people have tried it already. very quickly, that could reach a lot more people. there are 40 million smokers in the u.s. >> okay. guys, you heard what matt had to say. now we need to work out whether you are in or whether you are out on quit tea. joe, you first. >> this seems like a bit of a holistic tea. that market is very, very crowded. i think that your consumer is very limited in the time span, especially if you are suggesting nine weeks of use, and i think another reason is i just think quit tea is a bad name. i'm out. >> what about you, chris? >> i'm very intrigued by this idea. it's not -- he's not pitching a chemical solution. he's pitching a behavioral one, which of course could go into other places of addiction, everything else. i'm impressed by the young man, that's profitable and self-funded for two years, and though i've got a lot of big questions, i would spend time with this guy. i'm in. >> it can be used as a supplement to other various measures you are taking to try and quit smoking. you know what, these days, i'm not a smoker but i have friends who are and they all say it's increasingly hard to find places whether it be an eating place or public place to be able to smoke. i think the regulatory environment certainly supports trying to quit. i'm going to say i'm in. okay? you've got one out and two in. matt, what's your reaction? >> i appreciate the vote of confidence and i'm really excited you guys had me on to get the word out about quit tea. >> thank you so much. also to our panelists, joe and chris. that, folks, is today's power pitch. >> you heard what the panel had to say but we want to hear from you. are you in or out on quit tea? log on to powerpitch.cnbc.com or tweet your thoughts wi with #powerpitch. talking about power, everyone in my native land, my father's native land, norway, is now theoretically a millionaire, even the people in his hometown. that's because the sovereign wealth fund over there in norway has hit a new all time high due in part to high oil and gas prices. the fund also has lots of stock and bond investments that haven't hurt. the fund is worth $828 billion. the population of norway is just over five million people. you do the math, it works out to, what, about $1.3 million for every norwegian. sue? >> not bad. thanks, ty. let's get back to the markets right now. stocks are kind of mixed today after yesterday's big move up in the dow. can the gains from 2013 continue and where are the best places to make money in the market this year? here with us at the nyse is cnbc market analyst kenny polcari and from minneapolis, jeff brewer, ceo of the brewer group. jack, i will start with you. first of all, happy birthday. we are so glad you could spend your birthday with us here on "power lunch." great to see you again. >> thank you, sue. >> let's start with what you're doing in the new year in terms of market moves and allocating capital for your clients. do you think we are going to have a pretty decent year in terms of equity gains? >> yes, i do. we remain very bullish in the health care sector. some of our stocks have really rebounded, they pulled back a bit late in the fourth quarter of 2013, but we think with obamacare and the continuation of the improvements there, that we will have some substantial gains. we are very excited about that. we also like europe. i think there's a lot of opportunity in the financial sector in europe. i think if we continue to see a recovery there, that those stocks will also perform very well. >> you know, jack is one of many that we have talked to that have been bullish now on europe and it's been a correct call so far. >> right. i agree. i think we have been talking about that a number of times. we said it, if you believe in this global recovery, certainly europe is a place where people should have some investments. i also think here in the states, we go back to us at home, i think next year, this 2014 is going to be a good year for large caps, kind of this back to basic mentality of investing that i have where people now are getting much more comfortable once again with equity investing and much more comfortable with individual names, so therefore, i think big americana industrial tech names are really going to do well this year. >> jack, what about yield? i know a number of your clients are concerned about income, concerned about yield. where are you finding that for them at this point? >> it's a tough environment right now. we are also investing pretty heavily in high yield and high yield space. and we are also staying bullish on municipalities. we think last year was a very poor year in the market for munis and going into 2014, i think if you keep the quality high and you invest in high quality munis you can get that extra yield in your portfolio. >> thanks, guys. appreciate it very much. happy birthday again, jack. >> thank you, sue. to the bond market now. rick santelli tracking the action at the cme after a ten year auction that got a hook. how's the market doing now? >> it was a hook and if you look at the ten year chart, you will see we're up five basis points. here's what everybody i asked on the floor answered indirectly. if you look back to the july historic lows, since then, we have only had two, yes, only two actual closes where 70% cash dealers had a 3% handle. this may be the third. that speaks volumes about how infatuated we are with 3% and investment grade corporates, we had ten deals at $12 billion yesterday. we have five deals looking to be $6 billion today. g.e. capital corp figures prominently in today's supply. back to you. >> rick, thank you very much. forget the nsa. auto makers are now tracking you in your car. we will explain that one and explain what it may mean. plus, microsoft narrows the ceo search but one thing is for sure here. mulally is out. who's in? we'll tell you. [ female announcer ] who are we? we are the thinkers. the job jugglers. the up all-nighters. and the ones who turn ideas into action. we've made our passions our life's work. we strive for the moments where we can say, "i did it!" ♪ we are entrepreneurs who started it all... with a signature. legalzoom has helped start over 1 million businesses, turning dreamers into business owners. and we're here to help start yours. everything looking good. ♪ velocity 1,200 feet per second. [ man #2 ] your looking great to us, eagle. ♪ 2,000 feet. still looking very good. 1,400 feet. ♪ [ male announcer ] funny thing happens when you shoot for the moon. ahh, that's affirmative. [ male announcer ] you get there. you're a go for landing, over. [ male announcer ] the all new cadillac cts, the 2014 motor trend car of the year. welcome back to "power lunch." we want to show you some video of aubrey lee price, the georgia banker who allegedly faked his own death in 2012 after allegedly stealing millions of dollars from investors in a bank in georgia. he was in court today. police arrested him last week after pulling him over because his car windows were tinted too dark. price entered a not guilty plea this morning and despite all the money he's accused of stealing, he has said he has no money for an attorney, so one was appointed for him. a number of investors also showed up for the hearing. guess what, price is being held without bond pending his trial on federal bank charges. remember, of course, that he was featured on an episode of cnbc's "american greed, the fugitive." that's the story on price. let's go to seema mody for a market flash. let's take a look at shares of mcdonald's, at session lows right now. the fast food chain was downgraded by wells fargo to market perform from outperform while reducing its price target to $102 from $108 a share. the firm says the company has lost market share in the u.s. in three of the last four months. through november, shares down about 1.3%. sue? >> seema, thank you. bob pisani with quick market check. we mentioned that health care and financials were big winners. a couple groups are struggling. i want to put up the luxury retailers. they've had a tough time of it this year. movado, kors, all to the downside. another company with tough times in the retail, jc penney. they said they were pleased with their holiday performance period, but that's not good enough here. they reaffirmed the forecast but didn't give any specific numbers and everybody said gee, why didn't they tell us what the numbers were if they were so pleased. i got questions about very large put activity in jc penney just prior to the close yesterday. apparently it was three times bigger. that's raised questions about did anybody know anything. i don't know what the answer to that is, but we did know an announcement was coming. they hadn't trumpeted anything prior to that. it's quite possible somebody made a guess. tough call on this one. >> stock down 8%. that's a big hit. thanks. appreciate it. one thing we do know, ford's alan mulally will not be microsoft's new ceo. who will be? josh lipton breaks it down. >> reporter: mulally is out, analysts telling me this will be a big problem for gates and the board. i will tell you why when "power lunch" continues. and now my journey across the country has brought me to the lovely city of boston. cheers. and seeing as it's such a historic city, i'm sure they'll appreciate that geico's been saving people money for over 75 years. oh... dear, i've dropped my tea into the boston harbor. huhh... i guess this party's over. geico. fifteen minutes could save you fifteen percent or more on car insurance. of the dusty basement at 1406 35th street the old dining table at 25th and hoffman. ...and the little room above the strip mall off roble avenue. ♪ this magic moment it is the story of where every great idea begins. and of those who believed they had the power to do more. dell is honored to be part of some of the world's great stories. that began much the same way ours did. in a little dorm room -- 2713. ♪ this magic moment ♪ ♪ [ male announcer ] eeny, meeny, miny, go. ♪ ♪ more adventures await in the new seven-passenger lexus gx. lease the 2014 gx 460 for $499 a month for 27 months. see your lexus dealer. welcome back to "power lunch." i'm seema mody. it's been a strong day for yelp. jpmorgan raising the price target to $89 a share from $75 a share. the firm citing yelp's strong local ad coverage. tyler and sue, back to you. >> thank you very much. we're watching microsoft today, along with a lot of other people. the software giant said to be close to naming its new ceo. one thing we do know, it won't be ford's alan mulally. josh lipton is in silicon valley with the latest list for us. >> reporter: yeah, this is a tough ceo search and it just got tougher. ford's ceo alan mulally saying he will remain at ford through at least 2014, ending speculation that he will be microsoft's next ceo. israel hernandez of mkm says the problem here is tension in the microsoft boardroom. activists want a financial engineer. gates and palmer seem to want a technologist. speculation now turning to a number of microsoft insiders. there is the former nokia ceo who understands mobile technology, worked at microsoft before taking over nokia. analysts do question his tenure at nokia where the stock nosedived 60%. then you have another contender, nadella, who heads up the cloud group but microsoft is in different business lines like mobile. the question then is whether he can answer those challenges. kevin turner, microsoft's coo, he knows microsoft inside out but picking turner signals the board is sticking with the status quo and that obviously could upset activists. dan ives says one outsider to watch, paul merritt from pivotal, a tech veteran, he understands the cloud and next-gen data centers. one theme i did hear when talking to analysts about these candidates, not a lot of enthusiasm for any of them. what they did agree on was this. there are big challenges for microsoft in this post-pc world, regardless of who ends up winning the top job. tyler, back to you. >> thank you very much. the 50th anniversary of the nation's war on poverty. did it work? backlash by the bay. we'll tackle that one. silicon valley workers under fire out there for some of the perks they get. and auto makers are tracking you in your car. the power rundown is next. tdd#: 1-800-345-2550 trading inspires your life. tdd#: 1-800-345-2550 life inspires your trading. tdd#: 1-800-345-2550 where others see fads... tdd#: 1-800-345-2550 ...you see opportunities. tdd#: 1-800-345-2550 at schwab, we're here to help tdd#: 1-800-345-2550 turn inspiration into action. tdd#: 1-800-345-2550 we have intuitive platforms tdd#: 1-800-345-2550 to help you discover what's trending. tdd#: 1-800-345-2550 and seasoned market experts to help sharpen your instincts. tdd#: 1-800-345-2550 so you can take charge tdd#: 1-800-345-2550 of your trading. a very sort of disparate number of topics on the power rundown today. today marks the 50th anniversary of president johnson's big promise. >> as the session which declared all-out war on human poverty and unemployment in these united states. >> the war on poverty. that's the yahoo! finance question of the day. did we win it or not. i guess 13% say yes, it's helped millions of americans. 65% say no, inequality is a bigger problem than ever. 22% saying it's an ongoing battle and more needs to be done. there's a lot of talk these days about income inequality and whether that is going to be sort of the intellectual issue of 2014 remains to be seen, but certainly, the new mayor of new york thinks it is. >> right. new york is often a bellwether for other big cities to come. certainly you can't argue with the 65% number that says this is still the biggest issue of our time. interesting, a lot of those pieces of legislation that johnson enacted are now some of the biggest thorns in some of our conversations today in washington legislatively. we have a much more difficult -- >> whole departments like hud and the education department and others spawned medicare, medicaid, came out of that food stamps, head start and the like. it's a very different political culture today. back then we were still sort of in touch with one foot with the roosevelt years. now, more in touch, let me just posit, with the reagan era. >> that's the key here. the reason why is there was a concerted effort by all of america to realize it was a huge problem. now it's become more of a debate point. you have your occupy wall street and everything else. that's the reason why it will be such a big deal. >> interesting conversation. it will be on the front burner for much of this year. the fight between people in san francisco and those who work in silicon valley heating up. the city plans now to regulate, tax, basically, the shuttles that take workers from downtown san francisco out to the google, facebook and apple campuses. among the changes, fees based on the number of stops the shuttles make at city bus stops. good idea or not? they will go anywhere to get the revenue. >> it's interesting because state laws in california don't allow you to just collect it and use it for anything. you got to plow it back into the system to regulate it. what's more interesting here is tens of thousands of employees work in silicon valley and live in san francisco and take these shuttles. it's the same thing in new york city. >> we have shuttles that bring people out from new york city to here. >> we do. >> ever been on it? >> i have, too many times. i can't go there. can't go there. 35,000 people, though, that's a lot of people. lot of revenue. >> let's squeeze in the last one. big brother really watching. gm, ford, chrysler, foreign auto companies reportedly tracking and storing data from customers' cars through their on-board navigation systems, i guess like onstar and others, supposed to assist with traffic accidents, roadside emergencies. but how do drivers feel if your actions may be tracked? does it bother you? >> i always thought they would have the capability and they could potentially use it. the problem that i have with this is you can't opt out. if you have a car that's made by one of these auto makers in the report and they are using that data for these purposes, there is nowhere that you can say i want to raise my hand and say i want to opt out of this. >> i use realtime traffic apps. i would rather they track my data so i know where the traffic accidents are. >> all right, thank you very much. fed minutes could be market moving. we've got them at the top of the hour. we'll take a quick break. we'll be right back. ♪ ♪ ♪ [ tires screech ] chewley's finds itself in a sticky situation today after recalling its new gum. [ male announcer ] stick it to the market before you get stuck. get the most extensive charting wherever you are with the mobile trader app from td ameritrade. a body at rest tends to stay at rest... while a body in motion tends to stay in motion. staying active can actually ease arthritis symptoms. but if you have arthritis, staying active can be difficult. prescription celebrex can help relieve arthritis pain so your body can stay in motion. because just one 200mg celebrex a day can provide 24 hour relief for many with arthritis pain and inflammation. plus, in clinical studies, celebrex is proven to improve daily physical function so moving is easier. celebrex can be taken with or without food. and it's not a narcotic. you and your doctor should balance the benefits with the risks. all prescription nsaids, like celebrex, ibuprofen, naproxen and meloxicam have the same cardiovascular warning. they all may increase the chance of heart attack or stroke, which can lead to death. this chance increases if you have heart disease or risk factors such as high blood pressure or when nsaids are taken for long periods. nsaids, like celebrex, increase the chance of serious skin or allergic reactions or stomach and intestine problems, such as bleeding and ulcers, which can occur without warning and may cause death. patients also taking aspirin and the elderly are at increased risk for stomach bleeding and ulcers. don't take celebrex if you have bleeding in the stomach or intestine, or had an asthma attack, hives, other allergies to aspirin, nsaids or sulfonamides. get help right away if you have swelling of the face or throat, or trouble breathing. tell your doctor your medical history. and find an arthritis treatment for you. visit celebrex.com and ask your doctor about celebrex. for a body in motion. where does the united states get most of its energy? is it africa? the middle east? canada? or the u.s.? the answer is... the u.s. ♪ most of america's energy comes from right here at home. take the energy quiz. energy lives here. all right. we are just moments away from the minutes of the last fed meeting. we just saw the ten year note tick above the 3% mark. the dow is holding basically flat from where it was when we came in. it's down 68 points. the s&p is up just a fraction. the nasdaq is the strongest of the three indices, up a third of a percent. three etf winners right now, all health care related. ty? >> see you when you get back. the breaking news from the fed starts right now. welcome to a big edition of "street signs." we are just seconds away from the release of the fed minutes. december was when they announced the taper. this is where we stand. the dow is down by 70 points. the ten year is back below the 3% mark. gold as you can see here behind me, is down by five bucks. let's get to steve liesman with all the details of the fed minutes because it was a very important meeting and people have been waiting what they had to say. >> reporter: this was the meeting where the federal reserve tapered and at that meeting, most participants saw the taper as appropriate as a cautious first step. many saw the economic progress compared certainly to october and over the course of quantitative easing as meaningful. now, there was a debate about this. several were concerned about tapering with the high unemployment rate and low inflation. some preferred a larger taper, even a few of them wanted qe limits and a completion date to be published. many supported at the end, many supported modest taper along with the rate guide, that dovish rate guide. there was a debate at this meeting about actuall